A team from Shriners Children's and Washington University in St. Louis are investigating a new method for personalizing ...

The Food and Drug Administration has approved a device that uses electrical stimulation to reduce inflammation from rheumatoid arthritis.

Results show that GLP-1s may address rheumatoid arthritis (RA) symptoms, independent of established weight loss and cardiac benefits, by reducing the systemic, chronic inflammation associated with RA.

A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile ...

Introduction: Treatments for rheumatoid arthritis (RA) and osteoarthritis (OA) can reduce, modulate inflammation, and reduce deformities. Low-Level Laser Therapy is a biomodulator and may aid in the ...

Millions of Americans are now taking GLP-1 medications, and the drugs are affecting their lives in about as many ways — far beyond the numbers on the scale. (Photo illustration: Yahoo News; photos: ...

Sinomenine (SIN), a multi-target alkaloid extracted from Sinomenium acutum, demonstrates significant immunomodulatory, anti-inflammatory, and osteoprotective properties in the treatment of rheumatoid ...

Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as “miracle drugs,” not only because they help people lose weight, but because they’ve also been shown to help with many ...

Living with rheumatoid arthritis (RA) can feel like an endless battle, facing pain, stiffness, and despair when the body can’t function optimally. For 58-year-old Dawn Steiner, it meant losing the ...

Although there are a range of drugs that can treat rheumatoid arthritis (RA), they can all have significant side effects. “Some are common and some not so common,” says Diane Horowitz, MD, an ...